Suppr超能文献

远程缺血预处理治疗坏死性小肠结肠炎:I 期可行性和安全性研究。

Remote ischaemic conditioning in necrotising enterocolitis: a phase I feasibility and safety study.

机构信息

Division of Neonatology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Translational Medicine, Hospital for Sick Children Research Institute, University of Toronto, Toronto, Ontario, Canada.

出版信息

Arch Dis Child Fetal Neonatal Ed. 2023 Jan;108(1):69-76. doi: 10.1136/archdischild-2022-324174. Epub 2022 Aug 8.

Abstract

OBJECTIVE

Remote ischaemic conditioning (RIC) improves the outcome of experimental necrotising enterocolitis (NEC) by preserving intestinal microcirculation. The feasibility and safety of RIC in preterm infants with NEC are unknown. The study aimed to assess the feasibility and safety of RIC in preterm infants with suspected or confirmed NEC.

DESIGN

Phase I non-randomised pilot study conducted in three steps: step A to determine the safe duration of limb ischaemia (up to 4 min); step B to assess the safety of 4 repeated cycles of ischaemia-reperfusion at the maximum tolerated duration of ischaemia determined in step A; step C to assess the safety of applying 4 cycles of ischaemia-reperfusion on two consecutive days.

SETTING

Level III neonatal intensive care unit, The Hospital for Sick Children (Toronto, Canada).

PATIENTS

Fifteen preterm infants born between 22 and 33 weeks gestational age.

INTERVENTION

Four cycles of ischaemia (varying duration) applied to the limb via a manual sphygmomanometer, followed by reperfusion (4 min) and rest (5 min), repeated on two consecutive days.

OUTCOMES

The primary outcomes were (1) feasibility defined as RIC being performed as planned in the protocol, and (2) safety defined as perfusion returning to baseline within 4 min after cuff deflation.

RESULTS

Four cycles/day of limb ischaemia (4 min) followed by reperfusion (4 min) and a 5 min gap, repeated on two consecutive days was feasible and safe in all neonates with suspected or confirmed NEC.

CONCLUSIONS

This study is pivotal for designing a future randomised controlled trial to assess the efficacy of RIC in preterm infants with NEC.

TRIAL REGISTRATION NUMBER

NCT03860701.

摘要

目的

远程缺血预处理(RIC)通过保护肠道微循环来改善实验性坏死性小肠结肠炎(NEC)的预后。RIC 在患有 NEC 的早产儿中的可行性和安全性尚不清楚。本研究旨在评估 RIC 在疑似或确诊 NEC 的早产儿中的可行性和安全性。

设计

在三个步骤中进行的 I 期非随机试验研究:步骤 A 确定肢体缺血的安全持续时间(最长可达 4 分钟);步骤 B 评估在步骤 A 确定的最大耐受缺血时间内重复 4 个缺血-再灌注循环的安全性;步骤 C 评估连续两天应用 4 个缺血-再灌注循环的安全性。

地点

加拿大 SickKids 医院三级新生儿重症监护病房。

患者

15 名胎龄 22 至 33 周的早产儿。

干预

通过手动血压计对肢体施加 4 个循环的缺血(持续时间不同),随后再灌注(4 分钟)和休息(5 分钟),连续两天重复。

结果

主要结局为(1)按方案计划进行 RIC 定义为可行性;(2)定义为袖带放气后 4 分钟内血流恢复到基线定义为安全性。

结论

本研究对于设计未来的随机对照试验评估 RIC 在患有 NEC 的早产儿中的疗效至关重要。

试验注册号

NCT03860701。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d68a/9763186/8b43aed5f24d/fetalneonatal-2022-324174f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验